Gastro Medical News about premixed parenteral nutrition

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Use of Antiemetic Agents in Acute Gastroenteritis

3. 2008 Exclusive Survey—Earnings: Good news for primary care income

4. A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity

5. Medicare pay-for-reporting effort draws fire from frustrated doctors

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Commercial Premixed Parenteral Nutrition: Is It Right for Your Institution?
Nutrition in Clinical Practice, 07/23/09

Miller SJ – Two–compartment premixed parenteral nutrition (PN) products are heavily promoted in the United States. These products may present safety advantages over PN solutions mixed by a local pharmacy, although clinical data to support this assertion are scarce. Multicompartment products can be labor–saving for pharmacy and therefore may be cost–effective for some institutions. Before adopting such products for use, an institution must determine that standardized PN solutions are acceptable for many or most of their patients compared with customized PN compounded specifically for individual patients. A larger selection of premixed products is available in Europe and some other parts of the world compared with the United States. Availability of a broader selection of products in the United States, including 3–compartment bags and a wider range of macronutrient concentrations and volumes, may make the use of such products more desirable in the future.

<< Previous
EUS-guided ethanol versus saline solution lavage for pancreatic...

Next >>
Pregnancy after living-related liver transplantation associated...